132 related articles for article (PubMed ID: 3114444)
21. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL
Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792
[TBL] [Abstract][Full Text] [Related]
22. Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes.
Delgado DH; Rao V; Hamel J; Miriuka S; Cusimano RJ; Ross HJ
J Heart Lung Transplant; 2005 Sep; 24(9):1343-6. PubMed ID: 16143255
[TBL] [Abstract][Full Text] [Related]
23. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of immunosuppression in cyclosporine-treated heart transplant patients with lymphoma.
Brumbaugh J; Baldwin JC; Stinson EB; Oyer PE; Jamieson SW; Bieber CP; Henle W; Shumway NE
J Heart Transplant; 1985 May; 4(3):307-11. PubMed ID: 3039097
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
26. Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipients.
Schroeder TJ; Melvin DB; Clardy CW; Wadhwa NK; Myre SA; Reising JM; Wolf RK; Collins JA; Pesce AJ; First MR
J Heart Transplant; 1987; 6(2):84-9. PubMed ID: 3305834
[TBL] [Abstract][Full Text] [Related]
27. Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report.
Gilbert EM; Renlund DG; O'Connell JB; Eiswirth CC; Rothstein G; Gay WA; Bristow MR
J Heart Transplant; 1987; 6(6):369-74. PubMed ID: 3320307
[TBL] [Abstract][Full Text] [Related]
28. Arteriolar vasculitis on endomyocardial biopsy: a histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients.
Herskowitz A; Soule LM; Ueda K; Tamura F; Baumgartner WA; Borkon AM; Reitz BA; Achuff SC; Traill TA; Baughman KL
J Heart Transplant; 1987; 6(3):127-36. PubMed ID: 3309214
[TBL] [Abstract][Full Text] [Related]
29. Are steroids essential for successful maintenance of immunosuppression in heart transplantation?
Katz MR; Barnhart GR; Szentpetery S; Rider S; Thompson JA; Hess M; Hastillo A; Lower RR
J Heart Transplant; 1987; 6(5):293-7. PubMed ID: 3316555
[TBL] [Abstract][Full Text] [Related]
30. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
[TBL] [Abstract][Full Text] [Related]
31. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
McDiarmid SV; Busuttil RW; Ascher NL; Burdick J; D'Alessandro AM; Esquivel C; Kalayoglu M; Klein AS; Marsh JW; Miller CM
Transplantation; 1995 Feb; 59(4):530-6. PubMed ID: 7533345
[TBL] [Abstract][Full Text] [Related]
32. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
33. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
34. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Cantarovich M; Latter DA; Loertscher R
Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
[TBL] [Abstract][Full Text] [Related]
35. Late acute cardiac allograft rejection: new therapeutic options?
Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
[TBL] [Abstract][Full Text] [Related]
36. [Follow-up of heart transplants].
Mosseri M; Admon D; Yarom R; Rosenheck S; Gotsman MS
Harefuah; 1989 Jan; 116(1):17-21. PubMed ID: 2651234
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine: an immunosuppressive panacea?
Copeland JG; Emery RW; Levinson MM; Icenogle TB; Riley JE; McAleer MJ; Copeland JA; Dietz R
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):26-39. PubMed ID: 3079849
[TBL] [Abstract][Full Text] [Related]
38. Capillary and myofiber ultrastructure in endomyocardial biopsies from cyclosporine-treated heart transplant patients.
Yarom R; Admon D; Ron N; Mosseri M; Sapoznikov D; Gotsman MS
J Heart Transplant; 1990; 9(3 Pt 1):187-96. PubMed ID: 2355271
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation.
Myre SA; Schroeder TJ; Melvin DB; Pesce AJ; Collins JA; Stephens GW; First MR
Transplant Proc; 1989 Feb; 21(1 Pt 3):2484-6. PubMed ID: 2650310
[No Abstract] [Full Text] [Related]
40. Improved immunosuppression for heart transplant patients using intravenous doses of cyclosporine.
Macris MP; Frazier OH; Van Buren CT; Lammermeier DE; Kahan BD
Transplantation; 1989 Feb; 47(2):311-4. PubMed ID: 2493177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
